Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagent induction chemotherapy: results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113)

202233 citationsJournal Articlegold Open Access

Authors

Ingo Hartlapp · Universitätsklinikum Würzburg

D. Valta-Seufzer · Comprehensive Cancer Center Mainfranken

Jens T. Siveke · Heidelberg University

Hana Algül · Klinikum rechts der Isar

Eray Goekkurt · University Cancer Center Hamburg

Gabriele Margareta Siegler · Paracelsus Medizinische Privatuniversität

Uwe M. Martens

Abstract

ClinicalTrials.govNCT02125136; https://clinicaltrials.gov/ct2/show/NCT02125136; EudraCT 2013-004796-12; https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-004796-12/results.

Topics & Keywords

Pancreatic and Hepatic Oncology Research Neuroendocrine Tumor Research Advances Gastrointestinal Tumor Research and Treatment

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: ESMO Open

Volume 7, Issue 4, pp. 100552-100552

DOI: 10.1016/j.esmoop.2022.100552

Field-Weighted Citation Impact: 3.04